🔎 Trials Near Me

Akèy › Miasteni grav

Etid klinik pou Miasteni grav ap rekrite nan Etazini

45 etid pou Miasteni grav ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07787247

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07647510

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT07217587

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07463521

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07501702

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

Zilucoplan for Severe gMG Exacerbations

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07215949

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06414954

AXIS MG Patient Registry

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07761026

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 64 · Fanm · Mizajou Aug 11, 2026 · NCT06940323

MuSK Myasthenia 1000 Study

Ap rekriteEtid obsèvasyon
Laj 7 a 99 · Tout sèks · Mizajou Aug 5, 2026 · NCT06259071

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Aug 3, 2026 · NCT07596901

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Jul 31, 2026 · NCT05265273

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06193889

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04951622

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.